PIERIS PHARMACEUTICALS, INC. (PIRS) Retained Earnings (Accumulated Deficit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Pieris Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2013 to 2024.
  • Pieris Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$320 M, a 5.35% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$320 M -$16.3 M -5.35% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$315 M -$24.5 M -8.45% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$310 M -$28.1 M -9.94% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$300 M -$27 M -9.92% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$304 M -$41.4 M -15.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$290 M -$33.3 M -12.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$282 M -$34.7 M -14% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 -$273 M -$41.5 M -18% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$262 M -$46.7 M -21.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 -$257 M -$45.7 M -21.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$248 M -$50.6 M -25.7% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 -$231 M -$48.4 M -26.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$216 M -$37.8 M -21.3% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 -$211 M -$37.2 M -21.4% Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$197 M -$23.6 M -13.6% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 -$183 M -$11.9 M -6.97% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$178 M -$18.7 M -11.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 -$174 M -$27.1 M -18.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$173 M -$38 M -28.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$171 M -$41.6 M -32.2% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$159 M -$30 M -23.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$147 M -$26.8 M -22.2% Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$135 M -$7.58 M -5.93% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$129 M -$8.49 M -7.03% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$129 M -$18.4 M -16.6% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$120 M -$17.6 M -17.2% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$128 M -$31.7 M -33% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 -$121 M -$30.8 M -34.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 -$111 M -$26.6 M -31.7% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$103 M -$22.8 M -28.5% Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$96.1 M -$19.1 M -24.9% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$89.9 M -$16.9 M -23.1% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 -$84 M -$14.5 M -20.9% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$79.9 M -$14.1 M -21.4% Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$77 M -$76.9 M -257270% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 -$73 M -$73 M -456811% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$69.5 M -$69.5 M -710800% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 -$65.8 M -$9.85 M -17.6% Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$29.9 K* Sep 30, 2014 10-Q 2014-11-13
Q2 2014 -$16 K* -$15.7 K -5734% Jun 30, 2014 10-Q 2014-11-13
Q1 2014 -$9.78 K* Mar 31, 2014 10-Q 2014-06-02
Q4 2013 -$56 M Dec 31, 2013 10-K 2015-03-30
Q2 2013 -$274* Jun 30, 2013 10-K 2014-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.